Adult Glioblastoma: Strategies, Challenges and Opportunities
Posted on: Tuesday, 21 October 2008, 12:00 CDT
VOORHEES, N.J., Oct. 21 /PRNewswire/ -- Glioblastomas account for more than half of all newly diagnosed gliomas in the United States. Healthcare professionals face many challenges in the treatment of glioblastoma, as therapy today remains largely palliative.
Recent clinical trials have shown that combining surgery, radiation, and chemotherapy extends survival in a subset of patients, particularly when the chemotherapeutic agent temozolomide is included in the treatment approach. Other potentially promising therapies for glioblastoma under investigation include regional drug administration, targeted biologic therapies, vaccines, and genomic profiling. As research continues, new agents for adult glioblastoma are expected to further extend survival.
It is urgent that healthcare professionals working with this patient population stay informed about the most effective treatment strategies currently being utilized as well as emerging therapies as they become available.
To address the need for current education on the management of glioblastoma in adults, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education virtual lecture titled Adult Glioblastoma: Strategies, Challenges and Opportunities. This activity is supported by an educational grant from Schering-Plough, and is accredited for physicians, pharmacists, and registered nurses.
Faculty chairperson for this virtual lecture is Marc C. Chamberlain, MD, Professor of Neurology & Neurological Surgery and Chief of the Division of Neuro-Oncology at the University of Washington and a leading expert in the development of clinical trials for primary brain tumors.
Healthcare professionals can access this virtual lecture by visiting http://cme.medscape.com/viewprogram/17259.
"Quality continuing education is vital to developing and increasing knowledge and skills and enhancing patient care," says Robert Michael Educational Institute President and CEO, Robert M. Colleluori.
RMEI is a medical education company that specializes in independent, accredited, and nonaccredited education. The goal of all accredited RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.
For other educational opportunities, please visit http://www.rmei.com/.
Robert Michael Educational Institute
CONTACT: Erin McCabe of Robert Michael Educational Institute,+1-866-770-RMEI
Web site: http://cme.medscape.com/viewprogram/17259http://www.rmei.com/
Source: PRNewswire
Related Articles
- Laser Spine Institute Tampa Receives Coveted AAAHC Accreditation
- Bridgepoint Education's Academic Institutions Join Transparency by Design Consortium
- Higher Education Level, Greater Disability Linked With Treatment Timing In Parkinson's Disease
- J. Craig Venter Institute Names Robert Friedman, Ph.D., Deputy Director of West Coast Facility
- Edison Schools Establishes Education Research Institute, Names New Chief Education Officer
- National Marfan Foundation Leads Educational Efforts for Correct Diagnosis and Treatment of Aortic Dissection in Hospital Emergency Departments
- The Book 'Managing Chronic Obstructive Pulmonary Disease' Provides Insight into the Management of COPD at Home and in Hospital; Including Drug Treatments, Oxygen Therapy, and Non-Invasive Ventilation is Discussed
- Robert Michael Educational Institute LLC Announces Personnel Changes
- Source Technologies Hosts Financial Self-Service eForum to Educate Financial Institutions, Billers, and Retailers; Online Event Discusses Next-Generation Financial Kiosk Technology and Applications
- Update on National Asthma Education and Prevention Program Pediatric Asthma Treatment Recommendations
 |
 |
User Comments (0)
RSS Feeds